News Biogen Receives EMA’s CHMP Positive Opinion for Tofidence (Biosimilar, Roactemra)ByDipanshu DixitApril 25, 20240Comments
VIEWPOINTS Technology Infusion: Raviv Pryluk Sheds Light on PhaseV’s Recent Collaboration with 9xchange Biopharma MarketplaceBySaurabh ChaubeyApril 23, 20240Comments
News The US FDA Grants Accelerated Approval to Day One’s Ojemda for Treating Pediatric Low-Grade Glioma (pLGG) ByDipanshu DixitApril 23, 20240Comments
INSIGHTS+ Insights+: EMA Marketing Authorization of New Drugs in March 2024ByDipanshu DixitApril 22, 20240Comments
News Samsung Bioepis Receives EC’s Marketing Authorization for Pyzchiva (Biosimilar, Stelara) to treat Autoimmune disordersByDipanshu DixitApril 22, 20240Comments
News ImmunityBio’s Anktiva Receives the US FDA’s Approval to Treat Non-Muscle Invasive Bladder Cancer (NMIBC) ByDipanshu DixitApril 22, 20240Comments
TOP 20 Top 20 Biopharma Deal Terminations of 2023 Based on Total Deal ValueByPrince GiriApril 18, 20240Comments
INSIGHTS+ Disease of the Month – Duchenne Muscular Dystrophy (DMD)BySaurabh ChaubeyApril 17, 20240Comments
